[Molecular indicators of neoplasia in clinical diagnostics]

Katarzyna Gawron1, Andrzej Wiczkowski, Brygida Adamek

  • 1Katedra i Zakład Ogólnej Biologii Lekarskiej Slaskiej Akademii Medycznej w Zabrzu-Rokitnicy. ksr@silesianet.pl

Insights

Mutations in key genes like proto-oncogenes and tumor suppressors disrupt cell growth control, leading to genome instability and cancer. These genetic alterations are crucial indicators for neoplasm diagnosis and prognosis.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Context:

  • Cellular growth and division are tightly regulated by genes including proto-oncogenes, suppressor genes, mismatch repair genes, and apoptotic genes.
  • Disruptions in these genes, through mutations, lead to DNA errors and uncontrolled cell proliferation.

Purpose:

  • To review mutations in proto-oncogenes, suppressor genes, mismatch repair system genes, and apoptotic genes.
  • To highlight the role of these mutations in genetically determined, predisposition syndromes, and sporadic neoplasms.
  • To emphasize their significance as molecular indicators in clinical diagnostics.

Summary:

  • Mutations in critical gene groups (proto-oncogenes, suppressor, mismatch repair, apoptotic) disrupt normal cellular regulation.
  • Accumulated DNA errors and loss of proliferation control result in genome instability and hyper-proliferation.
  • These mutations are frequently detected in neoplasms and impact clinical course and prognosis.

Impact:

  • Identifies key genetic markers for neoplasm development and progression.
  • Provides insights into the molecular basis of genetically determined and sporadic cancers.
  • Supports the use of these genetic mutations as diagnostic and prognostic indicators in clinical settings.

Related Concept Videos